Symptom - Low Libido

Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., Parish, S. J., Pinkerton, J. A., Rymer, J., Simon, J. A., Vignozzi, L., & Wierman, M. E. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Clinical Endocrinology & Metabolism, 104(10), 4660–4666.

Genazzani, A. R., Stomati, M., Valentino, V., Pluchino, N., Potì, E., Casarosa, E., Merlini, S., Giannini, A., & Luisi, M. (2011). Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric, 14(6), 661–668.

Ito, T. Y., Trant, A. S., & Polan, M. L. (2001). A Double-Blind Placebo-Controlled Study of ArginMax, a Nutritional Supplement for Enhancement of Female Sexual Function. Journal of Sex & Marital Therapy, 27(5), 541–549.

Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Apr;176(4):453-62. doi: 10.1001/jamainternmed.2015.8565. PMID: 26927498.

Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual Health in Menopause. Medicina. 2019; 55(9):559.

Soe LH, Wurz GT, Kao CJ, Degregorio MW. Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast. Int J Womens Health. 2013;5:605-611. Published 2013 Sep 25. doi:10.2147/IJWH.S39146

Vegunta S, Kling JM, Kapoor E. Androgen Therapy in Women. J Womens Health (Larchmt). 2020 Jan;29(1):57-64. doi: 10.1089/jwh.2018.7494. Epub 2019 Nov 5. Erratum in: J Womens Health (Larchmt). 2020 Nov;29(11):1487. PMID: 31687883.

West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of Low Sexual Desire and Hypoactive Sexual Desire Disorder in a Nationally Representative Sample of US Women. Arch Intern Med. 2008;168(13):1441–1449. doi:10.1001/archinte.168.13.1441